LeMaitre Vascular director exercises options for 3,444 shares

LMAT director John A. Roush exercised options for 3,444 shares and now holds 7,386 LMAT shares directly, plus 181 shares indirectly through his wife.

Rhea-AI Filing Summary

LEMAITRE VASCULAR INC (LMAT) director John A. Roush exercised employee stock options on September 1, 2026 to acquire 3,444 shares of common stock at an exercise price of $48.60 per share. Following the transaction, he held 7,386 shares directly and 181 shares indirectly through his wife. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

3,444 shares exercised/converted

Exercise 3 txns

Insider Roush John A

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F2	3,444	$0.00	$0.00
Exercise	Common Stock F1	3,444	$48.60	$167K
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 7,386 shares (Direct); Common Stock — 181 shares (Indirect, By wife)

Footnotes (2)

1. F1. Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
2. F2. This option is fully vested and exercisable.

Key Figures

Shares acquired via option exercise: 3,444 shares Exercise price: $48.60 per share Direct common shares held after transaction: 7,386 shares +3 more

6 metrics

Shares acquired via option exercise 3,444 shares Common stock acquired on September 1, 2026 by exercising options

Exercise price $48.60 per share Exercise price for 3,444 shares of common stock

Direct common shares held after transaction 7,386 shares Direct LMAT holdings of John A. Roush after September 1, 2026 transactions

Indirect common shares held after transaction 181 shares Indirect LMAT holdings by his wife after September 1, 2026

Option expiration date December 11, 2028 Expiration date of the exercised stock option

Option shares exercised 3,444 shares Stock option converted into common stock on September 1, 2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did LMAT director John A. Roush report in this Form 4?

He reported exercising options on September 1, 2026 to acquire 3,444 LMAT common shares at $48.60 per share, increasing his direct holdings to 7,386 shares and indirect holdings (through his wife) to 181 shares.

How many LMAT shares did John A. Roush acquire and at what price?

John A. Roush acquired 3,444 shares of LEMAITRE VASCULAR INC common stock at an exercise price of $48.60 per share through an option exercise reported on September 1, 2026.

What are John A. Roush’s LMAT share holdings after this transaction?

After the reported transactions, John A. Roush directly held 7,386 shares of LMAT common stock and indirectly held 181 shares through his wife as of September 1, 2026.

Were the LMAT option exercises by John A. Roush under a Rule 10b5-1 plan?

No. The filing indicates that no Rule 10b5-1 trading plan is reported in connection with the option exercise and resulting share acquisition on September 1, 2026.

What option position did John A. Roush exercise in LMAT?

He exercised stock options covering 3,444 shares of LMAT common stock with an exercise price of $48.60 per share. The option was fully vested and had an expiration date of December 11, 2028.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 04:54 PM EDT Accepted by SEC EDGAR 09/03/2026 - 04:37 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roush John A

(Last) (First) (Middle)

C/O LEMAITRE VASCULAR, 63 SECOND AVENUE

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/01/2026		M		3,444(1)	A	$48.6	7,386	D
Common Stock								181	I	By wife

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$48.6	09/01/2026		M			3,444	12/11/2021(2)	12/11/2028	Common Stock	3,444	$0	0	D

Explanation of Responses:

1. Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.

2. This option is fully vested and exercisable.

	/s/ Douglas G. Bush, Attorney-in-fact	09/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)